Results
Not losing weight on Ozempic? Common reasons and what to check
July 26, 2026 · 2 min read
The short answer
Not losing on Ozempic is usually explained by being early on a low dose, a normal plateau as the body adapts, undereating protein or overeating hidden calories, low activity, poor sleep, or the fact that Ozempic tops out at a lower dose (2 mg) than the weight version Wegovy (2.4 mg).
Most causes are fixable without abandoning the medication. Give each dose time, protect protein and muscle, track intake honestly, and take non-scale progress into account. Persistent stalls on a stable higher dose are worth reviewing with your prescriber.
First, is it actually a stall?
Weight loss is not linear. Water shifts, hormones, salt, and the menstrual cycle can hide fat loss for a week or two even when things are working. Before troubleshooting, look at the four-week trend rather than day-to-day numbers, and weigh under consistent conditions. A flat fortnight inside a downward trend is normal.
The common reasons
- You are still on a starting or low dose. Ozempic is titrated up slowly, and appetite suppression strengthens as you climb, so early plateaus often resolve at the next step-up. Our Ozempic dosing schedule shows the ladder.
- Ozempic tops out lower than the weight version. Ozempic's maximum is 2 mg, while the weight-approved twin Wegovy goes to 2.4 mg. If you have maxed Ozempic and still want more effect, that is worth discussing, since Wegovy is the on-label weight option. See our Ozempic for weight loss post.
- You have hit a normal plateau. As you lose weight, your body needs fewer calories, so the same intake becomes maintenance. Plateaus are expected and usually break with an adjustment.
- Not enough protein, too much of everything else. Under-eating protein costs muscle; liquid calories and larger portions than you think offset the deficit.
- Too little movement, poor sleep, and stress, which all blunt progress.
What to do about it
Give each dose a fair run. Track what you actually eat for a week and keep protein high. Add resistance training. Protect sleep. Weigh progress in more than pounds: measurements, how clothes fit, energy, and blood markers all count. Our general GLP-1 stall post and Wegovy stall post go deeper.
When to talk to your prescriber
If you are on a stable higher dose, eating and training well, sleeping enough, and still truly flat over a couple of months, it is worth a review, including whether the weight-approved Wegovy dose fits your goal. Your clinician can also check whether another condition is involved. Logging dose, weight, and intake together in DoseLog gives them the real pattern. This article is general information, not medical advice.
Questions people ask
Why am I not losing weight on Ozempic?
The usual reasons are still being on a low starting dose, a normal plateau, undereating protein or overeating hidden calories, too little activity, and the fact that Ozempic tops out at 2 mg versus Wegovy's 2.4 mg. Most are fixable without stopping the medication.
Why did Ozempic stop working for weight loss?
Often it is a normal plateau: as you lose weight your body needs fewer calories. It can also mean you are due a dose step-up, or that you have maxed Ozempic's lower dose. Review the four-week trend and your dose before concluding it failed.
Should I switch from Ozempic to Wegovy to lose more weight?
Possibly. They are the same drug, but Wegovy is the weight-approved version at a higher top dose (2.4 mg vs Ozempic's 2 mg). If you have maxed Ozempic with a good routine and want more effect, discuss switching with your prescriber.
What should I do if Ozempic isn't working?
Give each dose time, track intake honestly with high protein, add resistance training, protect sleep, and measure non-scale progress. If you are on a stable higher dose with a good routine and still flat for months, review it with your prescriber.
References
- 1.Ozempic and Wegovy (semaglutide) prescribing information: dosing, adverse reactions, and warnings. View label on DailyMed ↗
- 2.Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. STEP 1. NEJM 2021. Read on NEJM ↗
- 3.GLP-1 receptor agonist response variability and weight-loss plateau reviews. Find on PubMed ↗
This article is general education, not medical advice. DoseLog is a tracking and reflection tool. Decisions about your medication, dose, and symptoms belong with a licensed clinician.
Keep reading